phase readout
saveNCT07686042: Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis
NOT_YET_RECRUITINGupdated 10m ago
community read0 votes
Sponsor: Beijing Tiantan Hospital. Phase: PHASE4. Conditions: Autoimmune Encephalitis (AE), Autoimmune Cerebellitis
view source ↗
comments(0)
5-min edit window · permanent after that